Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novel therapeutic agents for neurological disorders reported in recent patents

April 18, 2007

Genetic studies allow creation of test for clozapine-induced agranulocytosis risk

April 18, 2007

Ccr2 protective in Alzheimer's disease

April 18, 2007

Alpha-lipoic acid studied for prevention of chemotherapy-induced neuropathy

April 17, 2007

Snapshots: Preclinical studies of agents under development for schizophrenia

April 17, 2007

Recent patents disclose new therapeutic agents for anxiety, depression and sleep disorders

April 17, 2007

Anti-Abeta fusion antibody successfully delivered to the brain through a molecular Trojan horse

April 17, 2007

Requip XL 24-Hour Extended-Release Tablets accepted for review

April 16, 2007

FDA approves new dose of Risperdal Consta for schizophrenia

April 16, 2007

NP-61 to begin clinical testing for Alzheimer's

April 16, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...